• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Jazz Pharma Plc (NQ: JAZZ )

    110.45 +0.42 (+0.38%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Nov 1, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 389,055
    Open 110.84
    Bid (Size) 110.00 (1)
    Ask (Size) 113.50 (1)
    Prev. Close 110.03
    Today's Range 109.89 - 111.22
    52wk Range 99.06 - 134.48
    Shares Outstanding 62,311,104
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    In-Depth Examination Of 12 Analyst Recommendations For Jazz Pharmaceuticals
    Via Benzinga
    Billionaire Seth Klarman Sold 64% of Baupost's Stake in Alphabet and Is Piling Into This Historically Cheap and Under-the-Radar Drugmaker
    Ardent value investor Seth Klarman is swapping out shares of search engine juggernaut Alphabet for a relatively unknown pharmaceutical stock that has a forward price-to-earnings ratio of 5! 
    Via The Motley Fool

    Performance

    YTD
    -12.98%
    -12.98%
    1 Month
    +0.68%
    +0.68%
    3 Month
    -2.48%
    -2.48%
    6 Month
    +0.40%
    +0.40%
    1 Year
    -14.27%
    -14.27%

    More News

    Read More
    Jazz Pharmaceuticals' Zepzelca/Tecentriq Combo Regimen Can Potentially Delay Disease Progression, Extend Survival In Aggressive Form Of Lung Cancer
    Via Benzinga
    NASDAQ:JAZZ is a prime example of a stock that offers more than what meets the eye in terms of fundamentals.
    Via Chartmill
    Assessing Jazz Pharmaceuticals: Insights From 12 Financial Analysts
    Via Benzinga
    Despite its impressive fundamentals, NASDAQ:JAZZ remains undervalued.
    Via Chartmill
    A Closer Look at 12 Analyst Recommendations For Jazz Pharmaceuticals
    Via Benzinga
    A Closer Look at 12 Analyst Recommendations For Jazz Pharmaceuticals
    Via Benzinga
    FDA-Approved Cannabis-Based Drug Shows Promising Results As A Treatment For War Veterans: Study Finds Improvement In Cognitive, Mood, Pain-Related Symptoms
    Via Benzinga
    When you look at NASDAQ:JAZZ, it's hard to ignore the strong fundamentals, especially considering its likely undervaluation.
    Via Chartmill
    Jazz And Hikma Accused Of Delaying Sleep Disorder Generic Drug To Maintain High Prices
    Via Benzinga
    'From Five Minutes Of Agony, It's Now Just Seconds,' Says Brazilian Mother Celebrating Free Access To Her Child's Life-Saving CBD Medicine
    Via Benzinga
    The Only FDA-Approved CBD Treatment For Severe Epilepsy Completes Key Phase 3 Trial In Japan Despite Missed Primary Goal
    Via Benzinga
    Decoding 11 Analyst Evaluations For Jazz Pharmaceuticals
    Via Benzinga
    How Is The Market Feeling About Jazz Pharmaceuticals?
    Via Benzinga
    Assessing Jazz Pharmaceuticals: Insights From 7 Financial Analysts
    Via Benzinga
    In a market where value is scarce, NASDAQ:JAZZ offers a refreshing opportunity with its solid fundamentals.
    Via Chartmill
    The 3 Best Cannabis Stocks to Buy in August 2024
    Via InvestorPlace
    Topics Cannabis
    Exposures Cannabis
    3 Biotech Stocks to Buy on the Dip: July 2024
    Via InvestorPlace
    Sage Therapeutics Collapses 21% After Biogen-Tied Essential Tremor Drug Fails
    Via Investor's Business Daily
    If You Can Only Buy One Biotech Stock in July, It Better Be One of These 3 Names
    Via InvestorPlace
    Is Big Pharma Poised To Take Over Cannabis? 3 Companies Already Manage 8 In 10 Drug Prescriptions In The US
    Via Benzinga
    Topics Cannabis
    Exposures Cannabis
    Avicanna Exports Cannabinoids To Singapore Legally — Even Though Cannabis Is Punishable By Death In The Country
    Via Benzinga
    Topics Cannabis
    Exposures Cannabis
    3 Mid-Cap Growth Rockets Trading at Deep Discounts to Their Potential
    Via InvestorPlace
    7 Biotech Stocks to Boost Your Portfolio to Peak Health
    Via InvestorPlace
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.